Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Talbot

Showing results (491-500 of 576) with videos related to

Pageof 58
Sort By:
British Journal of Cancer|July 17, 1998
Phase I study of the mitomycin C analogue BMS-181174V M Macaulay, K J O'Byrne, J A Green, et al.
Developmental Cell|March 11, 2023
Nuclear receptor Nr5a2 promotes diverse connective tissue fates in the jawHung-Jhen Chen, Lindsey Barske, Jared C Talbot, et al.
Angewandte Chemie (International Ed. in English)|August 2, 2005
Total synthesis of spongistatin 1: a synthetic strategy exploiting its latent pseudo-symmetryMatthew Ball, Matthew J Gaunt, David F Hook, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1997
A phase II study of mitomycin C and oral etoposide for advanced adenocarcinoma of the upper gastrointestinal tractJ P Braybrooke, K J O'Byrne, M P Saunders, et al.
British Journal of Cancer|May 3, 2002
Randomised, phase II trial comparing oral capecitabine (Xeloda) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclinesD C Talbot, V Moiseyenko, S Van Belle, et al.
Scientific Reports|June 24, 2021
Differences in molecular phenotype in mouse and human hypertrophic cardiomyopathyStyliani Vakrou, Yamin Liu, Li Zhu, et al.
Cureus|November 13, 2023
Infigratinib for the Treatment of Metastatic or Locally Advanced Cholangiocarcinoma With Known FGFR2 Gene Fusions or RearrangementsKathryn White, Ahmed I Anwar, Kevin Jin, et al.
British Journal of Cancer|May 19, 2011
Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancerO A Khan, A D Blann, M J Payne, et al.
Theranostics|July 21, 2011
Molecular Imaging and Pharmacokinetic Analysis of Carbon-11 Labeled Antisense Oligonucleotide LY2181308 in Cancer PatientsAzeem Saleem, Julian C Matthews, Malcolm Ranson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
A phase II study of etanercept (Enbrel), a tumor necrosis factor alpha inhibitor in patients with metastatic breast cancerSrinivasan Madhusudan, Martin Foster, Sethupathi R Muthuramalingam, et al.
Pageof 58

Showing results (491-500 of 576) with videos related to

Sort By:
Pageof 58
British Journal of Cancer|July 17, 1998
Phase I study of the mitomycin C analogue BMS-181174V M Macaulay, K J O'Byrne, J A Green, et al.
Developmental Cell|March 11, 2023
Nuclear receptor Nr5a2 promotes diverse connective tissue fates in the jawHung-Jhen Chen, Lindsey Barske, Jared C Talbot, et al.
Angewandte Chemie (International Ed. in English)|August 2, 2005
Total synthesis of spongistatin 1: a synthetic strategy exploiting its latent pseudo-symmetryMatthew Ball, Matthew J Gaunt, David F Hook, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1997
A phase II study of mitomycin C and oral etoposide for advanced adenocarcinoma of the upper gastrointestinal tractJ P Braybrooke, K J O'Byrne, M P Saunders, et al.
British Journal of Cancer|May 3, 2002
Randomised, phase II trial comparing oral capecitabine (Xeloda) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclinesD C Talbot, V Moiseyenko, S Van Belle, et al.
Scientific Reports|June 24, 2021
Differences in molecular phenotype in mouse and human hypertrophic cardiomyopathyStyliani Vakrou, Yamin Liu, Li Zhu, et al.
Cureus|November 13, 2023
Infigratinib for the Treatment of Metastatic or Locally Advanced Cholangiocarcinoma With Known FGFR2 Gene Fusions or RearrangementsKathryn White, Ahmed I Anwar, Kevin Jin, et al.
British Journal of Cancer|May 19, 2011
Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancerO A Khan, A D Blann, M J Payne, et al.
Theranostics|July 21, 2011
Molecular Imaging and Pharmacokinetic Analysis of Carbon-11 Labeled Antisense Oligonucleotide LY2181308 in Cancer PatientsAzeem Saleem, Julian C Matthews, Malcolm Ranson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
A phase II study of etanercept (Enbrel), a tumor necrosis factor alpha inhibitor in patients with metastatic breast cancerSrinivasan Madhusudan, Martin Foster, Sethupathi R Muthuramalingam, et al.
Pageof 58